Immunization, measles second dose in Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
Middle East, North Africa, Afghanistan & Pakistan (excluding high income): Immunization, measles second dose was 79.9% in 2024. ▲ Rising
Immunization, measles second dose in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), 2000–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children by the nationally recommended age.
Analysis
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) recorded 79.9% for immunization, measles second dose in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 1.5% on the previous year and up 21.6% over ten years.
Over the whole period, immunization, measles second dose in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) peaked at 79.9% in 2024 and was at its lowest, 33.1%, in 2000.
That places Middle East, North Africa, Afghanistan & Pakistan (excluding high income) 22nd out of 43 groups with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Immunization, measles second dose in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), year by year
| Year | % of children by the nationally recommended age | Change |
|---|---|---|
| 2000 | 33.1% | — |
| 2001 | 36.7% | +10.9% |
| 2002 | 36.8% | +0.2% |
| 2003 | 36.8% | -0.1% |
| 2004 | 41.3% | +12.2% |
| 2005 | 43.8% | +6.2% |
| 2006 | 45.3% | +3.4% |
| 2007 | 45.7% | +0.8% |
| 2008 | 43.7% | -4.3% |
| 2009 | 56.8% | +29.8% |
| 2010 | 58.5% | +3.0% |
| 2011 | 60.1% | +2.8% |
| 2012 | 59.6% | -0.8% |
| 2013 | 60.6% | +1.6% |
| 2014 | 65.7% | +8.5% |
| 2015 | 69.9% | +6.5% |
| 2016 | 75.9% | +8.5% |
| 2017 | 75.8% | -0.2% |
| 2018 | 74.9% | -1.2% |
| 2019 | 76.5% | +2.2% |
| 2020 | 77.5% | +1.2% |
| 2021 | 77.6% | +0.2% |
| 2022 | 78.0% | +0.5% |
| 2023 | 78.7% | +0.9% |
| 2024 | 79.9% | +1.5% |
Biggest year-on-year movements
Years where Immunization, measles second dose in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2009 | +29.8% | 43.7% | 56.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 42.0% | 33.1% | 56.8% | 10 |
| 2010s | 67.7% | 58.5% | 76.5% | 10 |
| 2020s | 78.3% | 77.5% | 79.9% | 5 |
Countries ranked near Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
- 19 Andorra 97.0% compare
- 19 Cyprus 97.0% compare
- 19 Guyana 97.0% compare
- 19 Saint Kitts and Nevis 97.0% compare
- 19 Tajikistan 97.0% compare
- 19 Tunisia 97.0% compare
- 25 Bhutan 96.0% compare
- 25 Egypt 96.0% compare
- 25 Japan 96.0% compare
- 25 Jordan 96.0% compare
- 25 South Korea 96.0% compare
- 25 Mauritius 96.0% compare
- 25 Portugal 96.0% compare
- 25 Saudi Arabia 96.0% compare
More health data for Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, annual growth rate 3.11 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0305 units per person (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 3.21 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0351 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 1.51 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0341 units per person (2025)
- Population ages 30-34, female, annual growth rate 0.4849 % change on previous year (2025)
All data for Middle East, North Africa, Afghanistan & Pakistan (excluding high income) →
Frequently asked questions
- What is immunization, measles second dose in Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- Immunization, measles second dose in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) was 79.9% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, measles second dose recorded in Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- The highest recorded value was 79.9% in 2024.
- What is the lowest immunization, measles second dose recorded in Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- The lowest recorded value was 33.1% in 2000.
- How does Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank for immunization, measles second dose?
- Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 22nd out of 43 groups with data for 2024.
- Is immunization, measles second dose rising or falling in Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- Over the last ten years it is up 21.6%. The long-run trend across the full record is rising.
- Where does this Middle East, North Africa, Afghanistan & Pakistan (excluding high income) data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, measles second dose (% of children by the nationally recommended age). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.